Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Houston › NPI 1679524961
Physician

Legacy Community Health Services, INC

Legacy Community Health Services, INC was paid $406.51M by Medicaid between Jan 2018 and Dec 2024, across 217 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 83% of everything it billed.

33Billing provider infoLEGACY COMMUNITY HEALTH SERVICES, INC
HOUSTON, TX 77006
33aNPI1679524961assigned 05/12/2006
33bProvider typePediatrics Physician
28Total paid$406.51M
24GClaims4,851,928
24DCodes billed217
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#1 of 1,136
Median peer was paid$329K
This provider vs. median1,237×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official PALUSSEK, ROBERT controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$5.0M$10M$15M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201821,000$3.70M
201931,232$4.31M
2020180,204$19.35M
2021700,453$81.02M
2022803,741$92.70M
20231,122,321$101.43M
2024incomplete1,992,977$104.01M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 83% 1,306,970 937,694 $336.74M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.1% 514,954 419,830 $20.78M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.2% 91,519 88,531 $9.11M
99381 1.6% 29,723 28,887 $6.39M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.5% 114,153 105,650 $6.26M
90834 Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient 1.4% 121,452 75,143 $5.76M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 75,453 73,838 $3.94M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 86,347 77,072 $3.35M
90832 Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient <1% 74,031 45,698 $2.76M
D0999 Unspecified diagnostic procedure, by report <1% 9,713 8,700 $2.24M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 36,912 35,982 $1.89M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 20,773 20,130 $1.15M
205 more codes
99203 Doctor's office visit, new patient (routine) <1% 17,764 $571K
90791 Psychiatric diagnostic evaluation <1% 9,834 $536K
G9012 Other specified case management service not elsewhere classified <1% 3,889 $533K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 940 $528K
90853 Group psychotherapy (other than of a multiple-family group) <1% 11,811 $499K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 5,062 $448K
99204 Doctor's office visit, new patient (more involved) <1% 10,626 $385K
90792 Psychiatric diagnostic evaluation with medical services <1% 6,880 $379K
99383 <1% 4,262 $376K
99382 <1% 2,733 $280K
99384 <1% 3,541 $263K
59430 <1% 8,380 $259K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 5,876 $175K
99385 <1% 1,093 $129K
99215 Doctor's office visit, returning patient (complex) <1% 1,798 $124K
G0467 Community health center visit, returning patient <1% 2,612 $99K
97169 <1% 5,121 $87K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 656 $85K
90837 Psychotherapy session, about an hour <1% 1,151 $71K
S0620 Routine ophthalmological examination including refraction; new patient <1% 1,239 $39K
90847 Family psychotherapy with the patient present, 50 minutes <1% 885 $34K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 172,770 $20K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,398 $20K
99205 Prolong outpt/office vis <1% 303 $15K
99050 <1% 3,465 $14K
90846 Family psychotherapy without the patient present, 50 minutes <1% 122 $13K
G2025 Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only <1% 681 $12K
G0470 Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit <1% 386 $12K
S0621 Routine ophthalmological examination including refraction; established patient <1% 344 $9K
V2025 Deluxe frame <1% 410 $9K
90472 Immunization administration, each additional vaccine (list separately) <1% 113,320 $9K
76801 <1% 12,245 $8K
90686 <1% 50,627 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 31,645 $8K
J7300 Intrauterine copper contraceptive (paragard) <1% 12 $8K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 25,752 $5K
V2020 Frames, purchases <1% 550 $5K
91322 <1% 787 $4K
81025 <1% 21,172 $4K
V2103 Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens <1% 468 $4K
90715 <1% 20,250 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 5,202 $3K
90621 <1% 3,025 $3K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 5,066 $3K
99401 <1% 26,980 $2K
90480 <1% 1,134 $2K
87428 <1% 57 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,086 $2K
11981 <1% 1,032 $2K
90670 <1% 43,537 $2K
90723 <1% 52,202 $2K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 12,756 $2K
99386 <1% 16 $2K
90648 <1% 65,218 $2K
3044F <1% 11,846 $1K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 2,539 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,727 $1K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 4,446 $1K
85018 <1% 14,566 $1K
90633 <1% 25,696 $1K
90710 <1% 7,808 $1K
90681 <1% 32,086 $886.29
92551 <1% 12,970 $872.07
87807 <1% 2,973 $865.04
A9150 Non-prescription drugs <1% 3,825 $864.51
99000 <1% 3,531 $846.69
90700 <1% 10,658 $762.28
D0150 Comprehensive oral evaluation - new or established patient <1% 1,379 $722.71
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 15 $721.36
3046F <1% 483 $660.00
90651 <1% 15,598 $562.65
V2750 Anti-reflective coating, per lens <1% 12 $530.99
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 3,647 $469.86
81002 <1% 5,856 $446.77
D0145 Oral evaluation for a patient under three years of age <1% 2,519 $436.00
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 1,085 $424.82
58300 <1% 288 $417.08
90734 <1% 9,160 $404.35
81003 <1% 5,392 $391.20
83026 <1% 8,545 $388.45
90716 <1% 12,468 $368.55
3051F <1% 148 $360.00
90460 Immunization administration through 18 years of age via any route, first or only component <1% 11,400 $349.63
D0220 Intraoral - periapical first radiographic image <1% 1,480 $335.18
J0561 Injection, penicillin g benzathine, 100,000 units <1% 496 $302.39
83036 Hemoglobin; glycosylated (A1C) <1% 1,423 $266.08
90696 <1% 7,255 $254.19
D0274 Bitewings - four radiographic images <1% 317 $236.66
D0120 Dental checkup, returning patient <1% 727 $199.10
D0230 Intraoral - periapical each additional radiographic image <1% 1,127 $135.61
D1206 Topical application of fluoride varnish <1% 1,472 $117.60
71046 Radiologic examination, chest; 2 views <1% 315 $93.35
0054A <1% 113 $80.00
0051A <1% 54 $80.00
17250 <1% 2,138 $75.22
D1120 Dental cleaning, child <1% 1,621 $73.50
90707 <1% 12,226 $66.49
90656 <1% 9,557 $66.47
D0330 Panoramic radiographic image <1% 187 $63.78
92557 <1% 47 $62.88
69209 <1% 447 $61.75
D0140 Limited oral evaluation - problem focused <1% 27 $32.00
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 210 $27.17
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 6,224 $25.40
D0272 Bitewings - two radiographic images <1% 312 $23.38
82247 <1% 1,694 $16.88
D1208 Topical application of fluoride, excluding varnish <1% 106 $14.70
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 649 $14.59
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 257 $14.31
86703 <1% 256 $11.52
99173 <1% 16,260 $4.34
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 504 $0.70
90461 <1% 3,639 $0.09
90746 <1% 372 $0.02
90677 <1% 23,114 $0.02
90474 <1% 6,399 $0.01
90785 0% 1,287 $0.00
1160F 0% 158,304 $0.00
99051 0% 12,462 $0.00
3725F 0% 250 $0.00
3078F 0% 114,832 $0.00
3077F 0% 3,796 $0.00
91300 0% 107 $0.00
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 0% 3,404 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 552 $0.00
0502F 0% 262 $0.00
90713 0% 1,117 $0.00
90714 0% 93 $0.00
3210F 0% 14,326 $0.00
96160 0% 176 $0.00
91321 0% 241 $0.00
1159F 0% 158,091 $0.00
1090F 0% 367 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 0% 174 $0.00
90380 0% 426 $0.00
59426 0% 13 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 0% 13 $0.00
83655 0% 29 $0.00
76818 0% 220 $0.00
97803 0% 24 $0.00
90750 0% 70 $0.00
96130 0% 25 $0.00
90655 0% 37 $0.00
0071A 0% 49 $0.00
2028F 0% 57 $0.00
80305 0% 26 $0.00
92552 0% 24 $0.00
69210 0% 14 $0.00
96137 0% 13 $0.00
D2391 Resin-based composite - one surface, posterior, primary or permanent 0% 16 $0.00
96136 0% 13 $0.00
91312 0% 15 $0.00
4000F 0% 3,706 $0.00
D0602 0% 1,655 $0.00
3074F 0% 125,675 $0.00
3079F 0% 19,352 $0.00
36415 Collection of venous blood by venipuncture 0% 4,883 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 435 $0.00
36416 0% 1,612 $0.00
2000F 0% 130,576 $0.00
91301 0% 33 $0.00
82962 0% 395 $0.00
3075F 0% 7,234 $0.00
J3490 Unclassified drugs 0% 651 $0.00
1000F 0% 88,479 $0.00
3008F 0% 85,699 $0.00
90688 0% 78 $0.00
D0603 0% 2,337 $0.00
90381 0% 640 $0.00
90744 0% 1,103 $0.00
3080F 0% 2,829 $0.00
1111F 0% 135 $0.00
1125F 0% 7,308 $0.00
D0601 0% 1,028 $0.00
2001F 0% 185,850 $0.00
J3535 Drug administered through a metered dose inhaler 0% 166 $0.00
91307 0% 29 $0.00
1126F 0% 50,235 $0.00
D2392 Resin-based composite - two surfaces, posterior, primary or permanent 0% 16 $0.00
D1330 0% 78 $0.00
1220F 0% 75,369 $0.00
97802 0% 69 $0.00
1036F 0% 394 $0.00
D1351 Sealant - per tooth 0% 58 $0.00
G0008 Administration of influenza virus vaccine 0% 99 $0.00
88720 0% 19 $0.00
90636 0% 26 $0.00
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) 0% 249 $0.00
90698 0% 100 $0.00
0052A 0% 13 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 0% 28 $0.00
86803 0% 14 $0.00
87081 0% 59 $0.00
93000 0% 19 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 47 $0.00
96127 0% 47 $0.00
96131 0% 12 $0.00
86780 0% 54 $0.00
90680 0% 101 $0.00
91305 0% 12 $0.00
J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg 0% 61 $0.00
1170F 0% 23 $0.00
87086 Culture, bacterial; quantitative colony count, urine 0% 21 $0.00
1034F 0% 14 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPALUSSEK, ROBERT (COO)
Same official

Other billing entities under PALUSSEK, ROBERT

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.